Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TM4SF4 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | SEP15 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | SPATA16 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | CRYBG3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | LIPN | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | BCAT1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | VTI1B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | C4BPA | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | OSBPL7 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | RAP2C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |